Home Dermira

Dermira

acquired
IPO Delisting
Biopharmaceutical Company

Basic Information

Dermira is a biopharmaceutical company dedicated to bringing the ingenuity of biotechnology to the field of medical dermatology. The company is committed to providing important new therapies for millions of patients suffering from chronic skin conditions. Dermira is devoted to understanding and addressing the needs of both patients and physicians. By leveraging its experience and insights, the company identifies and develops cutting-edge clinical programs in medical dermatology, aiming to transform the treatment of skin conditions by serving as a bridge between unmet patient needs and significant scientific advancements in the understanding of skin biology.
Dermira, Inc.
Palmdale,California,United States of America
101~500 people
January 01, 2010
info@dermira.com